{"version":1,"type":"rich","provider_name":"Libsyn","provider_url":"https:\/\/www.libsyn.com","height":90,"width":600,"title":"Navigating Cannabis Rescheduling: Key Insights for Healthcare","description":"Earlier this year, the DEA responded to President Biden\u2019s directive to reschedule cannabis from Schedule I to Schedule III of the Controlled Substances Act. This pivotal change, if finalized, would reclassify marijuana as a drug with moderate to low potential for dependence, strictly for medical use.&amp;nbsp; Chapters 00:00 Introduction to Workplace Issues and Cannabis Rescheduling 05:06 Understanding the Rescheduling Process of Cannabis 09:48 Implications of Rescheduling for Employers 15:07 Legal Challenges and Considerations for Healthcare Employers 19:50 Navigating Drug Testing and Employee Policies 24:51 Conclusion and Future Considerations ","author_name":"We get work\u00ae","author_url":"http:\/\/jacksonlewispc.libsyn.com\/website","html":"<iframe title=\"Libsyn Player\" style=\"border: none\" src=\"\/\/html5-player.libsyn.com\/embed\/episode\/id\/33824712\/height\/90\/theme\/custom\/thumbnail\/yes\/direction\/forward\/render-playlist\/no\/custom-color\/88AA3C\/\" height=\"90\" width=\"600\" scrolling=\"no\"  allowfullscreen webkitallowfullscreen mozallowfullscreen oallowfullscreen msallowfullscreen><\/iframe>","thumbnail_url":"https:\/\/assets.libsyn.com\/secure\/content\/180819987"}